BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16610367)

  • 1. Pharmacological targeting of catalyzed protein folding: the example of peptide bond cis/trans isomerases.
    Edlich F; Fischer G
    Handb Exp Pharmacol; 2006; (172):359-404. PubMed ID: 16610367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.
    Göthel SF; Marahiel MA
    Cell Mol Life Sci; 1999 Mar; 55(3):423-36. PubMed ID: 10228556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidyl prolyl cis/trans-isomerases: comparative reactivities of cyclophilins, FK506-binding proteins, and parvulins with fluorinated oligopeptide and protein substrates.
    Golbik R; Yu C; Weyher-Stingl E; Huber R; Moroder L; Budisa N; Schiene-Fischer C
    Biochemistry; 2005 Dec; 44(49):16026-34. PubMed ID: 16331962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.
    Perrucci GL; Gowran A; Zanobini M; Capogrossi MC; Pompilio G; Nigro P
    Cardiovasc Res; 2015 Jun; 106(3):353-64. PubMed ID: 25750190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl cis/trans isomerase signalling pathways in cancer.
    Theuerkorn M; Fischer G; Schiene-Fischer C
    Curr Opin Pharmacol; 2011 Aug; 11(4):281-7. PubMed ID: 21497135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide characterization of peptidyl-prolyl cis-trans isomerases in Penicillium and their regulation by salt stress in a halotolerant P. oxalicum.
    Singh M; Kaur K; Sharma A; Kaur R; Joshi D; Chatterjee M; Dandapath I; Kaur A; Singh H; Singh P
    Sci Rep; 2021 Jun; 11(1):12292. PubMed ID: 34112860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.
    Dunyak BM; Gestwicki JE
    J Med Chem; 2016 Nov; 59(21):9622-9644. PubMed ID: 27409354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl isomerases in yeast.
    Arevalo-Rodriguez M; Wu X; Hanes SD; Heitman J
    Front Biosci; 2004 Sep; 9():2420-46. PubMed ID: 15353296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases.
    Fanghänel J; Fischer G
    Front Biosci; 2004 Sep; 9():3453-78. PubMed ID: 15353370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl isomerases in a minimal cell. Catalysis of protein folding by trigger factor from Mycoplasma genitalium.
    Bang H; Pecht A; Raddatz G; Scior T; Solbach W; Brune K; Pahl A
    Eur J Biochem; 2000 Jun; 267(11):3270-80. PubMed ID: 10824113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and comparative analysis of sixteen fungal peptidyl-prolyl cis/trans isomerase repertoires.
    Pemberton TJ
    BMC Genomics; 2006 Sep; 7():244. PubMed ID: 16995943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.
    Rostam MA; Piva TJ; Rezaei HB; Kamato D; Little PJ; Zheng W; Osman N
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):117-24. PubMed ID: 25377120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protease-free assay for peptidyl prolyl cis/trans isomerases using standard peptide substrates.
    Janowski B; Wöllner S; Schutkowski M; Fischer G
    Anal Biochem; 1997 Oct; 252(2):299-307. PubMed ID: 9344417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl cis-trans isomerization as a molecular timer.
    Lu KP; Finn G; Lee TH; Nicholson LK
    Nat Chem Biol; 2007 Oct; 3(10):619-29. PubMed ID: 17876319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophilins and parvulins. Superfamily of peptidyl prolyl isomerases in Arabidopsis.
    He Z; Li L; Luan S
    Plant Physiol; 2004 Apr; 134(4):1248-67. PubMed ID: 15047905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational perspective and evaluation of plausible catalytic mechanisms of peptidyl-prolyl cis-trans isomerases.
    Ladani ST; Souffrant MG; Barman A; Hamelberg D
    Biochim Biophys Acta; 2015 Oct; 1850(10):1994-2004. PubMed ID: 25585011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone.
    Hennig L; Christner C; Kipping M; Schelbert B; Rücknagel KP; Grabley S; Küllertz G; Fischer G
    Biochemistry; 1998 Apr; 37(17):5953-60. PubMed ID: 9558330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of cyclosporins and other natural peptidyl prolyl cis/trans isomerase inhibitors.
    Lawen A
    Biochim Biophys Acta; 2015 Oct; 1850(10):2111-20. PubMed ID: 25497210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic mechanism and catalysis of a native-state prolyl isomerization reaction.
    Pappenberger G; Bachmann A; Müller R; Aygün H; Engels JW; Kiefhaber T
    J Mol Biol; 2003 Feb; 326(1):235-46. PubMed ID: 12547205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological Function of Pin1 in Vivo and Its Inhibitors for Preclinical Study: Early Development, Current Strategies, and Future Directions.
    He S; Li L; Jin R; Lu X
    J Med Chem; 2023 Jul; 66(14):9251-9277. PubMed ID: 37438908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.